1-3 of 3
Christine Le Maignan, MD
Close
Sort by
Journal Articles

GMCLI, Goelams Mantle Cell Lymphoma Index, a New Prognostic Index of Survival for MCL Patients Treated with VAD-C and Autologous PBSCT.

Remy Gressin, MD, Sylvie Caulet Maugendre, MD, Eric Deconinck, MD, Olivier Tournilhac, MD, Martine Dartigeas, MD, Marie Pierre Moles, MD, Gerard Lepeu, MD, Denis Guyotat, MD, Eric Legouffe, MD, Jacqueline Dugay, MD, Claude Martin, MD, Philippe Casassus, MD, Jean Pierre, Vilque, MD, Christiane Ghandour, MD, Isabelle Grulois, MD, Frederic Maloisel, MD, Christine Le Maignan, MD, Jean Pierre De Jaureguiberry, MD, Antoine Thyss, MD, Virginie Lucas, MD, Sylvie Cailleres, MD, Philippe Rodon, MD, Jean Luc Dutel, MD, Philippe Colombat, MD, Emmanuel Gyan, MD
Journal: Blood
Blood (2006) 108 (11): 2447.
https://doi.org/10.1182/blood.V108.11.2447.2447
Published: 2006
Journal Articles

Clinical Features and Prognostic Factors in 135 NHL of the Head and Neck Treated by the GOELAMS 02 Trial.

Laurent Laccourreye, MD, Bernard Desablens, MD, Christine Le Maignan, MD, Anne Le Mevel, MD, Christian Berthou, MD, Thierry Lamy, MD-PhD, Christiane Ghandour, François Guilhot, MD, Mathilde Hunault-Berger, MD-PhD, Henry Jardel, MD, Norbert Ifrah, MD, Philippe Colombat, MD, The GOELAMS Group
Journal: Blood
Blood (2005) 106 (11): 942.
https://doi.org/10.1182/blood.V106.11.942.942
Published: 2005
Journal Articles

Front-Line High-Dose Chemotherapy (HDT) Combined with Rituximab for Adults with Aggressive Large B-Cell Lymphoma (DLBCL) : Goelams 074 Trial.

Noel-Jean Milpied, MD, Thierry Lamy, MD, Philippe Casassus, MD, Eric Deconninck, MD, Remy Gressin, MD, Herve Maisonneuve, MD, Christine Le Maignan, MD, Jean-Francois Ramee, MD, Olivier Tournilhac, MD, Jacqueline Dugay, MD, Eric Legouffe, MD, Vincent Delwail, MD, Philippe Colombat, MD
Journal: Blood
Blood (2004) 104 (11): 902.
https://doi.org/10.1182/blood.V104.11.902.902
Published: 2004